UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 351

Sortiert nach

Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma

Journal of clinical oncology, 2008-12, Vol.26 (36), p.5950-5956

2008

Volltextzugriff (PDF)

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Journal of clinical oncology, 2006-10, Vol.24 (29), p.4738-4745

2006

Volltextzugriff (PDF)

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Investigational new drugs, 2011-06, Vol.29 (3), p.489-498

2011

Volltextzugriff (PDF)

A phase 2 clinical trial of nab‐paclitaxel in previously treated and chemotherapy‐naive patients with metastatic melanoma

Cancer, 2010-01, Vol.116 (1), p.155-163

2010

Volltextzugriff (PDF)

Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2178-2185

2008

Volltextzugriff (PDF)

Attack of the clones: reproductive interference between sexuals and asexuals in the Crepis agamic complex

Ecology and evolution, 2016-09, Vol.6 (18), p.6473-6483

2016

Volltextzugriff (PDF)

Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7785-7793

2005

Volltextzugriff (PDF)

Naturally occurring B-cell responses to breast cancer

Cancer Immunology, Immunotherapy, 2003-12, Vol.52 (12), p.715-738

2003

Volltextzugriff (PDF)

Clinical applications of dendritic cell vaccination in the treatment of cancer

Cancer Immunology, Immunotherapy, 2004-04, Vol.53 (4), p.275-306

2004

Volltextzugriff (PDF)

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

Journal of translational medicine, 2010-09, Vol.8 (1), p.89-89, Article 89

2010

Volltextzugriff (PDF)

Phase II Multicenter Trial of Maintenance Biotherapy After Induction Concurrent Biochemotherapy for Patients With Metastatic Melanoma

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6207-6212

2009

Volltextzugriff (PDF)

The Role of the CTLA4 Blockade in the Treatment of Malignant Melanoma

Cancer investigation, 2007-01, Vol.25 (7), p.613-631

2007

Volltextzugriff (PDF)

Antigen-Driven Oligoclonal Expansion of Tumor-Infiltrating B Cells in Infiltrating Ductal Carcinoma of the Breast

The Journal of immunology (1950), 2002-08, Vol.169 (4), p.1829-1836

2002

Volltextzugriff (PDF)

Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma

Clinical cancer research, 2001-08, Vol.7 (8), p.2285-2291

2001

Volltextzugriff (PDF)

Phase I Trial of Imexon in Patients With Advanced Malignancy

Journal of clinical oncology, 2007-05, Vol.25 (13), p.1779-1784

2007

Volltextzugriff (PDF)

A new type of synthetic peptide library for identifying ligand-binding activity

Nature (London), 1991-11, Vol.354 (6348), p.82-84

1991

Volltextzugriff (PDF)

Gene Delivery Using Ultrasound Contrast Agents

Echocardiography (Mount Kisco, N.Y.), 2001-05, Vol.18 (4), p.355-361

2001

Volltextzugriff (PDF)

Whole-brain radiation therapy in melanoma: an open question

The lancet oncology, 2010, Vol.11 (1), p.13-13

2010

Volltextzugriff (PDF)

Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma

Clinical Medicine Insights. Oncology, 2012-01, Vol.2012 (6), p.275-286

2012

Volltextzugriff (PDF)

phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

Cancer chemotherapy and pharmacology, 2010-07, Vol.66 (2), p.287-294

2010

Volltextzugriff (PDF)

A Phase I Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously Daily for 5 Consecutive Days Every 3 Weeks in Patients with Advanced Solid Tumors

Clinical cancer research, 2005-11, Vol.11 (21), p.7807-7816

2005

Volltextzugriff (PDF)

Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma

Clinical cancer research, 2000-10, Vol.6 (10), p.3904-3909

2000

Volltextzugriff (PDF)

Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application

Cancer Immunology, Immunotherapy, 2004-08, Vol.53 (8), p.705-714

2004

Volltextzugriff (PDF)

Dispersal and establishment traits provide a colonization advantage for a polyploid apomictic plant

American journal of botany, 2023-04, Vol.110 (4), p.e16149-n/a

2023

Volltextzugriff (PDF)

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Annals of oncology, 2015-11, Vol.26 (11), p.2267-2274

2015

Volltextzugriff (PDF)

1 – 25 von 351

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(322)
Mit Volltextzugriff
(298)

Publikationsform

Sprache

Englisch
(351)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

A phase 2 clinical trial of nab‐paclitaxel in previously treated and chemotherapy‐naive patients with metastatic melanoma

Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group

Attack of the clones: reproductive interference between sexuals and asexuals in the Crepis agamic complex

Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies

Naturally occurring B-cell responses to breast cancer

Clinical applications of dendritic cell vaccination in the treatment of cancer

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

Phase II Multicenter Trial of Maintenance Biotherapy After Induction Concurrent Biochemotherapy for Patients With Metastatic Melanoma

The Role of the CTLA4 Blockade in the Treatment of Malignant Melanoma

Antigen-Driven Oligoclonal Expansion of Tumor-Infiltrating B Cells in Infiltrating Ductal Carcinoma of the Breast

Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma

Phase I Trial of Imexon in Patients With Advanced Malignancy

A new type of synthetic peptide library for identifying ligand-binding activity

Gene Delivery Using Ultrasound Contrast Agents

Whole-brain radiation therapy in melanoma: an open question

Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma

phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

A Phase I Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously Daily for 5 Consecutive Days Every 3 Weeks in Patients with Advanced Solid Tumors

Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma

Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application

Dispersal and establishment traits provide a colonization advantage for a polyploid apomictic plant

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Suchergebnisse filtern